196 related articles for article (PubMed ID: 32740174)
21. Expression of Ki67 as potential biomarker in oral submucous fibrosis: An immunohistochemical study.
Kamala KA; Kanetkar SR; Datkhile KD; Sankethguddad S
Indian J Dent Res; 2022; 33(3):272-276. PubMed ID: 36656187
[TBL] [Abstract][Full Text] [Related]
22. Oral submucous fibrosis: An update on current theories of pathogenesis.
Arakeri G; Rai KK; Hunasgi S; Merkx MAW; Gao S; Brennan PA
J Oral Pathol Med; 2017 Jul; 46(6):406-412. PubMed ID: 28391620
[TBL] [Abstract][Full Text] [Related]
23. Oral submucous fibrosis: a clinicopathologic review of 205 cases in Indians.
Angadi PV; Rekha KP
Oral Maxillofac Surg; 2011 Mar; 15(1):15-9. PubMed ID: 20414694
[TBL] [Abstract][Full Text] [Related]
24. Molecular pathways of oral submucous fibrosis and its progression to malignancy.
Gayathri K; Malathi N; Gayathri V; Adtani PN; Ranganathan K
Arch Oral Biol; 2023 Apr; 148():105644. PubMed ID: 36804642
[TBL] [Abstract][Full Text] [Related]
25. Areca nut in pathogenesis of oral submucous fibrosis: revisited.
Angadi PV; Rao SS
Oral Maxillofac Surg; 2011 Mar; 15(1):1-9. PubMed ID: 20376683
[TBL] [Abstract][Full Text] [Related]
26. Genetic Susceptibility and Protein Expression of Extracellular Matrix Turnover-Related Genes in Oral Submucous Fibrosis.
Cheng RH; Wang YP; Chang JY; Pan YH; Chang MC; Jeng JH
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143101
[TBL] [Abstract][Full Text] [Related]
27. High risk of malignant transformation of oral submucous fibrosis in Pakistani females: A potential national disaster.
Mohiuddin S; Fatima N; Hosein S; Fatima N
J Pak Med Assoc; 2016 Nov; 66(11):1362-1366. PubMed ID: 27812049
[TBL] [Abstract][Full Text] [Related]
28. Oral microbiota alteration associated with oral cancer and areca chewing.
Zhong X; Lu Q; Zhang Q; He Y; Wei W; Wang Y
Oral Dis; 2021 Mar; 27(2):226-239. PubMed ID: 32649007
[TBL] [Abstract][Full Text] [Related]
29. Identification of a combined biomarker for malignant transformation in oral submucous fibrosis.
Bazarsad S; Zhang X; Kim KY; Illeperuma R; Jayasinghe RD; Tilakaratne WM; Kim J
J Oral Pathol Med; 2017 Jul; 46(6):431-438. PubMed ID: 27497264
[TBL] [Abstract][Full Text] [Related]
30. Dysplastic features relevant to malignant transformation in atrophic epithelium of oral submucous fibrosis: A preliminary study.
Sarode SC; Chaudhary M; Gadbail A; Tekade S; Patil S; Sarode GS
J Oral Pathol Med; 2018 Apr; 47(4):410-416. PubMed ID: 29478271
[TBL] [Abstract][Full Text] [Related]
31. Comparison of Immunohistochemical Markers in Oral Submucous Fibrosis and Oral Submucous Fibrosis Transformed to Oral Squamous Cell Carcinoma-A Systematic Review and Meta-Analysis.
Mohapatra D; Panda S; Mohanty N; Panda S; Lewkowicz N; Lapinska B
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511530
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
Sutariya RV; Manjunatha BS
J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
[TBL] [Abstract][Full Text] [Related]
33. Fibroblast Growth Factor (FGF-2) and Its Receptors FGFR-2 and FGFR-3 May Be Putative Biomarkers of Malignant Transformation of Potentially Malignant Oral Lesions into Oral Squamous Cell Carcinoma.
Nayak S; Goel MM; Makker A; Bhatia V; Chandra S; Kumar S; Agarwal SP
PLoS One; 2015; 10(10):e0138801. PubMed ID: 26465941
[TBL] [Abstract][Full Text] [Related]
34. Current protocols in the management of oral submucous fibrosis: An update.
Arakeri G; Rai KK; Boraks G; Patil SG; Aljabab AS; Merkx MAW; Carrozzo M; Brennan PA
J Oral Pathol Med; 2017 Jul; 46(6):418-423. PubMed ID: 28391602
[TBL] [Abstract][Full Text] [Related]
35. Salivary pooling: is it specific to particular regions in oral submucous fibrosis?
Arakeri G; Colbert S; Patil SG; Hale B; Merkx MA; Brennan PA
Br J Oral Maxillofac Surg; 2015 Mar; 53(3):275-8. PubMed ID: 25592220
[TBL] [Abstract][Full Text] [Related]
36. Estimation of Salivary 8-Hydroxydeoxyguanosine (8-OHdG) as a Potential Biomarker in Assessing Progression towards Malignancy: A Case-Control Study.
Nandakumar A; Nataraj P; James A; Krishnan R; K M M
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2325-2329. PubMed ID: 32856861
[TBL] [Abstract][Full Text] [Related]
37. Oral submucous fibrosis: a contemporary narrative review with a proposed inter-professional approach for an early diagnosis and clinical management.
Rao NR; Villa A; More CB; Jayasinghe RD; Kerr AR; Johnson NW
J Otolaryngol Head Neck Surg; 2020 Jan; 49(1):3. PubMed ID: 31915073
[TBL] [Abstract][Full Text] [Related]
38. Estimation and Comparison of Copper Content in Raw Areca Nuts and Commercial Areca Nut Products: Implications in Increasing Prevalence of Oral Submucous Fibrosis (OSMF).
Mathew P; Austin RD; Varghese SS; Manojkumar
J Clin Diagn Res; 2014 Jan; 8(1):247-9. PubMed ID: 24596787
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of oral submucous fibrosis among areca nut chewers: A systematic review and meta-analysis.
Yuwanati M; Ramadoss R; Kudo Y; Ramani P; Senthil Murugan M
Oral Dis; 2023 Jul; 29(5):1920-1926. PubMed ID: 35503720
[TBL] [Abstract][Full Text] [Related]
40. Oral submucous fibrosis, a clinically benign but potentially malignant disease: report of 3 cases and review of the literature.
Auluck A; Rosin MP; Zhang L; Sumanth KN
J Can Dent Assoc; 2008 Oct; 74(8):735-40. PubMed ID: 18845065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
